Maximal γ-globin expression in the compound heterozygous state for- 175 (G)γ HPPFH and β°39 nonsense thalassaemia: A case study

European Journal of Haematology

Volumn 58, Issue 5, 1997, Pages 320-325

  Pistidda, P ^a   Frogheri, L ^a   Guiso, L ^a   Manca, L ^b   Dore, F ^c   Mura, L ^a   Longinotti, M ^c  

^a CNR   (Italy)

^b Ist di Fisiol Gen e Chim Biol   (Italy)

^c UNIVERSITY OF SASSARI   (Italy)

Author keywords

175 (G) HPFH; 39 thalassaemia; globin expression

Indexed keywords

BETA GLOBIN; DNA; GAMMA GLOBIN; HEMOGLOBIN A2; HEMOGLOBIN F;

ADULT; ARTICLE; BETA THALASSEMIA; CASE REPORT; CONTROLLED STUDY; ERYTHROCYTE; GENE CLUSTER; GENE OVEREXPRESSION; HAPLOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; ITALY; MALE; NONSENSE MUTATION; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 0030840816     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.1997.tb01678.x     Document Type: Article

References (27)

1. STAMATOYANNOPOULOS G, NIENHUIS AW. Hemoglobin switching. In: STAMATOYANNOPUOLOS G, NIENHUIS AW, MAJERUS PW, VARMUS H, eds. The Molecular Basis of Blood Diseases. Philadelphia: WB Saunders, 1994: 107-111.
2. MANTOVANI R, MALGARETTI N, NICOLIS S, RONCHI A, GIGLIONI B, OTTOLENGHI S. The effects of HPFH mutations in the human γ-globin promoter on binding of ubiquitous and erythroid specific nuclear factors. Nucleic Acids Res 1988: 16: 7783-7797.
3. MARTIN DIK, TSAI SF, ORKIN SH. Increased γ-globin expression in a nondeletion HPFH mediated by an erythroid-specific DNA-binding factor. Nature 1989: 338: 435-438.
4. OTTOLENGHI S, MANTOVANI R, NICOLIS S, et al. Altered binding to the γ-globin promoter of two erythroid specific nuclear proteins in different HPFH syndromes. Prog Clin Biol 1989: 316A: 229-236.
5. NICOLIS S, RONCHI A, MALGARETTI N, MANTOVANI R, GIGLIONI B, OTTOLENGHI S. Increased erythroid-specific expression of a mutated HPFH γ-globin promoter requires the erythroid factor NFE-1. Nucleic Acids Res 1989 : 17: 5509-5516.
6. GUMUCIO DL, LOCKWOOD WK, WEBER JL, et al. The -175 T→C mutation increases promoter strength in erythroid cells: correlation with evolutionary conservation of binding sites for two trans-acting factors. Blood 1990: 75: 756-761.
7. Gγ-globin promoter. Blood 1988: 71: 815-817.
8. CRAIG JE, SHEERIN SM, BARNETSON R, THEIN SL. The molecular basis of HPFH in a British family identified by heteroduplex formation. Br J Haematol 1993: 84: 106-110.
9. +HPFH. Blood 1988: 71: 807-810.
10. WEATHERALL DJ, CLEGG JB. Hereditary persistence of fetal hemoglobin. In: WEATHERALL DJ, CLEGG JB, eds. The Thalassaemia Syndromes, 3rd edn. Oxford: Blackwell Scientific Publications, 1981: 472-473.
11. GRIFFITHS WJ. Estimation of creatine in red cells. J Clin Pathol 1968: 21: 412-413.
12. 4 column. J Liquid Chromatogr 1984: 7: 1969-1977.
13. ORKIN SH, KAZAZIAN HH, ANTONARAKIS SE, et al. Linkage of β-thalassaemia mutations and β-globin gene polymorphisms with DNA polymorphisms in human β-globin cluster. Nature 1982: 296: 627-631.
14. +-HPFH heterozygotes using the DNA-amplification-synthetic oligonucleotide procedure. Blood 1988: 71: 1414-1417.
15. Aγ-hereditary persistence of fetal hemoglobin in northern Sardinia: its molecular basis and hematologic phenotype in heterozygotes and compound heterozygotes with β-thalassemia. Hum Genet 1988: 79: 13-17.
16. OTTOLENGHI S, MANTOVANI R, NICOLIS S, RONCHI A, GIGLIONI B. DNA sequences regulating human globin gene trascription in nondeletional hereditary persistence of fetal hemoglobin. Hemoglobin 1989: 13: 523-541.
17. LONGINOTTI M, MASALA B, TIDORE M, et al. Hematological and byosynthetic features of β°-thalassemia with an associated α-thalassemia. Hemoglobin 1989: 5: 619-625.
18. Aγ HPFH and β°39 nonsense thalassemia. Am J Hematol 1995: 49: 267-270.
19. 2 in patients with different β-thalassemia mutations and δ chain variant. Blood 1990: 76: 1246-1249.
20. Aγ expression in adult. Br J Haematol 1988: 68: 455-458.
21. T promoter. Br J Haematol 1991: 78: 105-107.
22. Aγ globin chain polymorphism and DNA polymorphism of the human β gene cluster in β thalassemia. Mol Biol Med 1984: 2: 301-306.
23. T in different populations, and its use in evaluating γ gene expression in association with thalassemia. Hum Genet 1985: 71: 127-133.
24. Aγ globin gene coincides with decreased gene expression. Hum Genet 1992: 89: 625-628.
25. Gγ-globin gene in cis. Am J Hematol 1994: 47: 307-311.
26. Gγ-globin synthesis. Am J Hematol 1993: 42: 186-190.
27. + (-87)-thalassemia CACCC box mutation is associated with elevated fetal hemoglobin in cis. Am J Hematol 1994: 45: 265-267.